| Description | EtDO-P4 is a nanomolar inhibitor of sphingolipid (GSL) synthesis. etDO-P4 inhibits EGFR-induced activation of the ERK pathway and various receptor tyrosine kinases (RTK). etDO-P4 can be used to study a variety of tumor types, such as Burkitt's lymphoma. |
| molecular weight | 516.76 |
| Molecular formula | C31H52N2O4 |
| CAS | 245329-78-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |